Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Advocate Shares Experience Raising Awareness and Advancing Research for Congenital Lyme Disease
- 5/9/2024 1:04:18 PM
- Bruce Fries of the Patient Centered Care Advocacy Group has been advocating for patients with Lyme disease since 2014. In the article, “Raising Awareness and Advancing Research for Congenital Lyme Disease,” he shares the story of how he organized an ad hoc group that became known as Mothers Against Lyme and worked with NIH to advance research on congenital Lyme disease.
- AstraZeneca completes equity investment agreement with Cellectis
- 5/8/2024 10:12:26 AM
- AstraZeneca announced the successful completion of an equity investment with Cellectis, a clinical-stage biotechnology company. The equity investment and a research collaboration agreement, announced in November 2023 will leverage the Cellectis proprietary gene editing technologies and manufacturing capabilities, to design up to 10 novel cell and gene therapy products for …
- VALOX™ HX325HP Resin for High-Precision Diabetes Management Devices, Offering Excellent Processability & Chemical Resistance
- 5/8/2024 9:40:53 AM
- • New VALOX HX325HP resin meets international standards of biocompatibility and change management. • This unreinforced polybutylene terephthalate (PBT) resin has predictable processing and performance properties, including excellent mold release, flexible sterilization options and high environmental stress cracking (ESC) resistance.
- Bridging disciplinary and sectoral silos to strengthen pandemic preparedness and response
- 5/8/2024 7:41:13 AM
- The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amidst uncertainty.
- Medicare trustees warn of payment issue’s impact on access to care
- 5/7/2024 9:58:15 AM
- Echoing warnings from the American Medical Association (AMA), Medicare trustees warned that the physician payment system has failed to keep up with the cost of practicing medicine and that failure could hinder seniors’ access to health care.
- Explainable AI Evaluated for Safe & Effective Integration of LLMs in Healthcare
- 5/6/2024 8:00:00 AM
- New research has been published in Telehealth and Medicine Today (THMT) peer reviewed journal. Original research topics include critical discussion points for explainable AI in healthcare, keeping up with generative intelligence, electronic medical records in the EU, telehealth for ICU patients, and remote specialty telehealth consultations.
- Integrity Orthopaedics Announces Closure of Series B Financing
- 5/3/2024 9:58:19 AM
- Integrity Orthopaedics, Inc., a company pioneering next generation solutions for soft tissue repair, has successfully closed on a Series B financing of $20.6 million. The financing was co-led by Piper Sandler Merchant Banking and an undisclosed existing investor. The company intends to use the capital to expand the US commercial launch of its initial product in the rotator …
- Remepy Launches with $15 Million in Funding To Bring First Hybrid Drug To Market
- 5/1/2024 10:53:04 AM
- Remepy, a pioneer in “hybrid drugs,” today announced that it has successfully closed a $10M seed investment round, which together with earlier funding totals $15M.
- “Art Therapy Workbook for Trauma Healing and PTSD Recovery” Will Be Free to Download Today at 05/01/2024
- 5/1/2024 6:00:00 AM
- With “Art Therapy Workbook” Rahel Bruegger, licensed art therapist in Switzerland, provides a self-guided exercise workbook for PTSD recovery and trauma healing.
- Treating cancer when neither chemotherapy nor transplant works
- 5/1/2024 3:11:30 AM
- Without the most common side effects, with improvement from the first days and complete remission after 18 months in almost 70% of cases. A clinical trial of CAR-T therapies coordinated by the Hospital Clínic Barcelona - IDIBAPS, with the support of the”la Caixa” Foundation, has brought the word curable almost within touching distance for multiple myeloma, the second most …
- New Episode of Medtech POV Podcast: Nanowear CEO Venk Varadan Details Medtech Startup Journey, Regulatory Pathway, and Payment Hurdles Facing Industry
- 4/25/2024 11:08:27 AM
- The newest episode of Medtech POV with Scott Whitaker, out on all podcast streaming platforms, highlights Venk Varadan’s journey as a medtech entrepreneur.
- AMA responds to UnitedHealth confirmation of stolen data from Change Healthcare
- 4/25/2024 11:03:14 AM
- The American Medical Association (AMA) is deeply concerned about the April 22 announcement from UnitedHealth Group (UHG) indicating vast amounts of sensitive medical data might have been stolen from Change Healthcare’s system and in the hands of malicious ransomware groups.
- ACCIONA Energía signs renewable PPA with DaVita in Spain
- 4/24/2024 12:29:15 PM
- • 12-year contract: The supply will come from the Ayora I-II-III photovoltaic complex in Jarafuel (Valencia), currently under development ACCIONA Energía has signed a power purchase agreement (PPA) with DaVita, leading medical services provider specialized in dialysis and kidney care services, to supply it with 100% renewable electricity in Spain for 12 years.
- Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
- 4/23/2024 2:18:20 PM
- Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) on Wednesday, May 29th, at the New York Hilton Midtown, New York, NY.
- NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients
- 4/20/2024 10:09:30 PM
- What In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses data from individual cells inside tumors to predict whether a person’s cancer will respond to a specific drug.
- Maxxcanna Launches Limited-Time 30% Off on 420 Sale on All Items
- 4/20/2024 10:03:36 PM
- Maxxcanna, a leading Canada-based weed brand renowned for its commitment to quality and innovation in creating premium CBD and THC products, has announced its exclusive 4/20 sale this year.
- Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say
- 4/18/2024 7:41:21 AM
- New evidence-based research calls into question the conventional three-month blanking period immediately after atrial fibrillation (AF) ablation, when early occurrences of AF are thought not to predict long-term AF recurrence.
- BrandShield and the Pharmaceutical Security Institute Release Annual Report Showing More than 6,900 Fraudulent Drug Listings and 1,600 Rogue Pharmacies Removed
- 4/15/2024 12:11:24 PM
- BrandShield together with the Pharmaceutical Security Institute, today announced its second annual Pharma Crime report carried out from January 2023 to December 2023.
- $6.9 Billion Weight Loss Telehealth Market Grows, But Gets Crowded
- 4/15/2024 6:00:00 AM
- April 15, 2024 - Marketdata LLC, a leading market research firm tracking the weight loss market since 1989, has released a new report: “The Telehealth Weight Loss Market”.
- AdvaMed to CMS: “1,138 Days Without Breakthrough Coverage is Harming Seniors”
- 4/12/2024 11:48:52 AM
- AdvaMed, the Medtech Association, unveiled a timer on the organization’s website to track the number of days since the Centers for Medicare and Medicaid Services (CMS) ended the coverage pathway for FDA-approved breakthrough medical devices.